Remove topics medicine
article thumbnail

Novartis Highlights Progress in Creating Sustainable Value for Stakeholders and Society in Novartis in Society Integrated Report 2023

3BL Media

Novartis delivered a strong performance in 2023, advancing new treatments for serious diseases and broadening access to our medicines. Our performance highlights the progress we are making in delivering on our purpose to reimagine medicine to improve and extend people’s lives. We also invested USD 98.4

article thumbnail

Building a Better Future: Bristol Myers Squibb 2023 ESG Report

3BL Media

That’s why, in 2023, we engaged a number of stakeholders, including patient advocacy partners, shareholders, suppliers, employees, multinational organizations and our Board to understand their views on ESG topics most important to our business and to society.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

To Us, It’s Personal: Viatris Colleagues Talk Access

3BL Media

That is why we are kicking off a program to listen to and engage with colleagues across the company on this topic: how access impacts each of us, our families and our communities globally. And we understand, on a deep and foundational level, the role that access plays in our ability to live healthier lives.

article thumbnail

Free Webinar: Leadership and a Reimagined Approach to Corporate Equity

3BL Media

Join FSG and the Shared Value Initiative on November 29 at 10:30AM ET for a reimagined approach to equity with a Global Fortune 500 CEO who is reimagining the ways his company uses innovative science, technology, and an “inspired, curious, unbossed” culture to deliver greater access to medicines. Vas Narasimhan, M.D. ,

article thumbnail

Novartis Highlights Focus on Creating Value for Stakeholders and Society in New Integrated Report

3BL Media

DESCRIPTION: At Novartis, we work to build trust with society and deliver long-term value to our stakeholders by embedding environmental, social and governance (ESG) topics into the core of our business strategy and operations. Significant impact on the world: Our medicines reached 766 million patients in 2021, with 56.2

article thumbnail

Gilead Sciences Inaugural Data Science Symposium

3BL Media

A big topic of the day was diversity – both diversity of thought and of people in the field – and how it can be a big driver of discovery, development and delivery. is a research-based biopharmaceutical company that discovers, develops and commercializes innovative medicines in areas of unmet medical need. View original content here.

article thumbnail

More Short Videos on Relevant and Timely Topics

Caux Round Table

We recently posted more short videos on relevant and timely topics. – The Medicine of the Moral Sense – Harvard and Free Speech All our videos can be found on our YouTube page here. They include: – Debt is an Illness – Is Capitalism Being Replaced?

62